The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment – SAGE Program Underwriters

29 Jun 2020 07:00

RNS Number : 2940R
B.P. Marsh & Partners PLC
29 June 2020
 

29 June 2020

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Investment - SAGE Program Underwriters

 

B.P. Marsh and Partners Plc (AIM:BPM), the specialist private equity investor in early stage financial services businesses is pleased to announce that it has agreed to subscribe for a 30% Cumulative Preferred Ordinary shareholding in SAGE Program Underwriters ("SAGE"), for an equity consideration of $250,000 (c. £200,000).

 

Based in Bend, Oregon, USA, and established in 2019, by CEO Chuck Holdren, SAGE provides specialist insurance products to niche industries, initially in the inland delivery and field sport sectors. 

 

Mr Holdren has over 3 decades of experience in the insurance industry. Prior to establishing SAGE, he founded and managed two national underwriting agencies from start-up to successful trade sale. He has also worked in senior management roles across the insurance sector. 

 

During his career, Mr Holdren has designed and implemented numerous underwriting programs for niche insurance sectors and has many long-lasting relationships with agents, brokers, and insurers across the USA. 

 

Before making this investment, the Company assessed the potential impact of the Covid-19 pandemic on SAGE. Given SAGE's focus on the Inland Delivery sector, a business segment that has continued to operate during the wider Covid-19 close down, the Company believes that SAGE is well positioned to trade through Covid-19. 

 

In addition to the equity consideration, the Company will provide a loan facility to SAGE of $250,000 (c. £200,000). This facility is available from completion and will be utilised by SAGE to bring about future growth, as outlined in the agreed business plan. 

 

Dan Topping, Chief Investment Officer of the Company, commenting on this investment, stated "We are pleased to be investing in SAGE, and we look forward to developing a successful partnership with Chuck and his team. He has a fine reputation for providing solutions to particular sectors which were previously underserved in the Workers Compensation insurance market. 

 

The specialist nature of SAGE within the insurance sector corresponds with our investment approach in seeking partnerships with skilled management teams." 

 

Chuck Holdren, SAGE's CEO, commented "We are thrilled to have B.P. Marsh as a partner in SAGE to help support our current and long-term goals. In addition to the financial investment, the team at B.P. Marsh brings a significant amount of insurance experience, expertise, and relationships. This allows SAGE to develop new programs, coverages and talent that we have already identified that will position us to be the leading insurance provider for the industries we serve." 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAPKPAANEEFA
Date   Source Headline
18th Jul 20172:07 pmRNSInvestee Company Update - Nexus Underwriting
13th Jul 20175:10 pmRNSInvestee Company Update
5th Jul 20173:25 pmRNSDirector/PDMR Shareholding
30th Jun 201710:36 amRNSInvestee Company Update - Nexus Underwriting
29th Jun 20173:26 pmRNSShare Incentive Plan
28th Jun 20173:07 pmRNSNotice of AGM
19th Jun 20173:20 pmRNSInvestment
14th Jun 20173:55 pmRNSDirector/PDMR Shareholding
14th Jun 20172:56 pmRNSDirector/PDMR Shareholding
13th Jun 20171:10 pmRNSInvestment in North America
12th Jun 20174:01 pmRNSDirector/PDMR Shareholding
12th Jun 20173:56 pmRNSDirector/PDMR Shareholding
9th Jun 20177:05 amRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSFinal Results
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
24th Apr 20174:40 pmRNSChange of Registered Office
19th Apr 20175:40 pmRNSResult of General Meeting
12th Apr 20174:07 pmRNSBesso Disposal Update
6th Apr 20175:36 pmRNSDirector/PDMR Shareholding
5th Apr 201712:28 pmRNSPDMR Share Sale Plan
3rd Apr 201712:43 pmRNSDisposal and Notice of General Meeting
16th Mar 20174:50 pmRNSTransaction in Own Shares
15th Mar 20175:04 pmRNSShare Buy-Back Policy Update
15th Mar 20175:02 pmRNSDirector/PDMR Shareholding
15th Mar 20172:47 pmRNSTransaction in Own Shares
14th Mar 20172:16 pmRNSTransaction in Own Shares
13th Mar 20173:56 pmRNSTransaction in Own Shares
10th Mar 20176:18 pmRNSTransaction in Own Shares
3rd Mar 20173:23 pmRNSTransaction in Own Shares
3rd Mar 20173:21 pmRNSDirector/PDMR Shareholding
3rd Mar 201711:12 amRNSShare Buy-Back Policy
28th Feb 20174:17 pmRNSDisposal
17th Feb 20174:36 pmRNSInvestment
7th Feb 20177:00 amRNSTrading Update
3rd Feb 201712:30 pmRNSDirector/PDMR Shareholding
30th Jan 20177:40 amRNSInvestment
10th Jan 20171:43 pmRNSDirector/PDMR Shareholding
5th Jan 20172:46 pmRNSPortfolio Update
4th Jan 20177:00 amRNSDisposal
15th Dec 20163:55 pmRNSFurther Investment in Nexus
22nd Nov 20163:45 pmRNSInvestment
18th Oct 20167:00 amRNSInterim Results
8th Sep 20167:00 amRNSTrading Update
26th Jul 20167:00 amRNSInvestee Company update
20th Jul 20165:07 pmRNSResult of AGM
5th Jul 20166:20 pmRNSDirector/PDMR Shareholding
1st Jul 201610:52 amRNSDividend Declaration
28th Jun 20164:41 pmRNSResponse to EU Referendum Result
28th Jun 20164:39 pmRNSShare Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.